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Modeling gene-regulatory networks to describe cell fate
transitions and predict master regulators
Pierre-Etienne Cholley1,2, Julien Moehlin1, Alexia Rohmer1, Vincent Zilliox1, Samuel Nicaise1, Hinrich Gronemeyer1 and
Marco Antonio Mendoza-Parra1,3
Complex organisms originate from and are maintained by the information encoded in the genome. A major challenge of systems
biology is to develop algorithms that describe the dynamic regulation of genome functions from large omics datasets. Here, we
describe TETRAMER, which reconstructs gene-regulatory networks from temporal transcriptome data during cell fate transitions to
predict “master” regulators by simulating cascades of temporal transcription-regulatory events.
npj Systems Biology and Applications  (2018) 4:29 ; doi:10.1038/s41540-018-0066-z
While previous efforts described cell fate transitions by the
reconstruction of transcription factor (TFs)-driven gene-regulatory
networks (GRNs) from the analysis of publicly available data (e.g.,
microarray transcriptomes;1,2 Cap Analysis of Gene Expression
(CAGE) data;3 enriched TF-DNA binding motif analysis4,5), none of
them considers the inherent temporal dimension of this process.
Also, neither provided a modular strategy for reconstructing
speciﬁc GRNs by incorporating novel information as it becomes
available in public databases.
Here, we present TETRAMER (TEmporal TRAnscription regulation
ModellER); a Cytoscape App that (i) reconstructs cell fate
transition-speciﬁc GRNs by integrating user-provided temporal
transcriptomes with a variety of pre-established TF-target gene
(TG) relationships issued from different types of public informa-
tion; (ii) predicts master regulator TFs by modeling temporal
transcriptional regulation propagation; and (iii) reveals the
temporal transcription-regulatory relationships between the TFs
participating in cell fate transition (Fig. 1). TETRAMER generates a
GRN that includes the temporal evolution of global transcription
by using information derived from three sources: GRNs con-
structed from a plethora of transcriptomes (CellNet1), the genome-
wide mapping of human promoters and enhancers in multiple cell
types/tissues by CAGE of the FANTOM5 consortium (regulatory
circuits3), and the systematic analysis of ChIP-seq information in
the NGS-QC database6 (http://ngs-qc.org) (Fig.1a).
While informative, the large size of the reconstructed networks
(several thousands of nodes and edges) restricts visual tracing of
the temporal evolution of the transcription regulatory cascades
driving the various types of cell fate transitions. TETRAMER
addresses this issue by simulating the propagation of the
temporal ﬂux of transcriptional regulation from any TF through
the reconstructed network by applying a set of logical rules
aiming to avoid the integration of information about TF–TG
relationships from heterologous cell/tissue systems, which may be
irrelevant for the particular cell fate transition (Fig. 1b, c and
Supplementary Fig. 1). Subsequently, TETRAMER evaluates the
fraction of regulated genes—relative to a deﬁned population (e.g.,
deﬁning the terminal state of the cell fate transition)—by any
given TF. This fraction; herein referred to as the master regulator
index (“MRI”); is further supported by the evaluation of its
conﬁdence relative to an MRI issued from the randomization of
the GRN connectivity. For this, TETRAMER generates multiple
randomly connected GRNs, on the basis of the same nodes and
number of edges (up to 100 times), from which a randomized MRI
distribution is computed (Supplementary Note). Finally, TETRAMER
ranks TFs according to their MRI and depicts the temporally
emerging transcription-regulatory landscape in Cytoscape (Fig. 1d
and Supplementary Fig. 1).
We have previously used this concept to deﬁne a temporal GRN
during retinoic acid-induced neuronal differentiation of embryonic
stem cells (ESCs).7 We reconstructed a GRN (>1900 nodes; >11,600
edges) from six subsequent transcriptomes and queried the
temporal evolution of transcription-regulatory cascades emanat-
ing from each TF. A subset of ~30 nodes presented MRIs higher
than 40% (p < 1 × 10−10; Supplementary Fig. 2). These nodes not
only comprised well-known neurogenic TFs, but also others poorly
characterized as major players in neurogenesis. Among them, the
early induced factors TAL2, GBX2, DMRT1, or LHX2 were
subsequently validated to drive neurogenesis in CRISPR-dCas9
gene activation assays.7
To illustrate its versatility, we used TETRAMER to reconstruct
dynamic GRNs implicated in iPS cell reprogramming (Supplemen-
tary Fig. 3), tumorigenic cell fate transformation (Supplementary
Fig. 4), and trans-differentiation of B-cell lymphomas to primary
macrophages (Fig. 2). Speciﬁcally, re-analysis of temporal tran-
scriptomes generated by Koga and colleagues8 for the repro-
gramming of MEFs to iPSCs identiﬁed 21 TFs with MRIs > 25% (p <
1 × 10−10). Among them, several factors implicated in the
maintenance of pluripotency and self-renewal of ESCs (SALL4,
SOX2, NANOG, NR0B1, or POU5F1) were shown to be activated at
late reprogramming stages (Supplementary Fig. 3). TETRAMER
predicted in addition several other factors that were previously
Received: 26 January 2018 Revised: 13 June 2018 Accepted: 21 June 2018
1Equipe Labellisée Ligue Contre le Cancer, Department of Functional Genomics and Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Centre National
de la Recherche Scientiﬁque UMR 7104, Institut National de la Santé et de la Recherche Médicale U964, University of Strasbourg, Illkirch, France
Correspondence: Hinrich Gronemeyer (hg@igbmc.u-strasbg.fr) or Marco Antonio. Mendoza-Parra (marco@igbmc.fr)
2Present address: Computational Systems Biology Infrastructure, Chalmers University of Technology, Kemivägen 10, 41296 Gothenburg, Sweden
3Present address: UMR 8030 Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, University of Evry-val-d’Essonne, University Paris-Saclay, 91057 Évry, France
www.nature.com/npjsba
Published in partnership with the Systems Biology Institute
reported to be involved in, or enhance reprogramming, like the
KLF4-interacting SWI/SNF catalytic subunit SMARCA2/BRM,9 the
DNA demethylase TET1, which can replace OCT4 in some
reprogramming cocktails,10 or the PRC2 subunit JARID2.11,12
We previously reported that tumorigenesis of pre-transformed
human ﬁbroblasts is induced by conditioned medium from
senescent cells.13 TETRAMER (Supplementary Fig. 4) revealed in
this system the induction of an immediate early gene program
involving proto-oncogenes (JUN, JUNB, MYC), suggested not only
tumor suppressors (EGR,14 KLF615), but also broad-spectrum
inﬂammatory regulators, like the ubiquitin-editing enzyme
TNFAIP3.16 The early program drives the temporal induction of
downstream NF-κB-mediated programs known to link inﬂamma-
tion and cancer (REL, RELB, NFKB, NFKB2),17 and the cytokine-
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Fig. 1 TETRAMER workﬂow to reconstruct TF regulatory networks by the integrating publicly available GRN information into temporal
transcriptomes. a TETRAMER reconstructs ﬁrst a temporal GRN for a cell fate transition by integrating publicly available GRN sources in the
temporal transcriptomes established for this transition. b Then the temporal propagation of the ﬂux of transcription regulatory information is
simulated across the entire GRN, thus establishing a comprehensive connectivity map between all nodes, which represent essentially TFs. For
computation, the transcriptional state of each node is discretized (0, 1, -1), as shown. c Propagation of the transcription regulatory information
applies three logical rules: (i) any connectivity to unresponsive nodes is eliminated, as the signal propagation is terminated; (ii) the ﬂux of
information should be coherent between the type of transcription regulation (positive or negative) and the discretized expression level of the
interconnected nodes; (iii) the directionality of the transcriptional regulation should comply with the temporal signal ﬂux. Nodes/edges that
do not comply with these rules are excluded from the GRN map, as they are not considered speciﬁc for the cell fate transition event.
Furthermore, nodes/edges downstream of the excluded events are neither considered (herein depicted in gray). d Within the reconstituted
GRN all nodes are ranked by their master regulator index (MRI), corresponding to the fraction of nodes that are regulated by a given TF upon
its activation and signal propagation. The relevance of this ranking is challenged by performing the same procedure in a GRN with
randomized connectivities. Thus, TETRAMER identiﬁes master regulator TFs among several thousand differentially expressed genes during cell
fate transitions
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Fig. 2 Reconstructing the TF regulatory network involved in B-lymphoma to macrophage trans-differentiation with TETRAMER. a TETRAMER
was used to model the TF regulatory network implicated in trans-differentiation of B-lymphoma cells to primary macrophages by over-
expression of CEBPA.19 b The information on temporal transcriptional regulation obtained from transcriptomes assessed during the ﬁrst 168 h
after CEBPA over-expression (GSE44700) was combined with the connectivity information obtained from three publicly available GRN sources
[CellNet; regulatory circuits established by the FANTOM consortium (regulatorycircuits.org) and systematic reanalysis of all publicly available
ChIP-seq datasets (ngs-qc.org)] to predict TFs that acted as master regulators of the trans-differentiation. Heat-maps of TFs identiﬁed by
integrating each of the three GRN sources were ranked according to their MRI for comparison. c C/EBPα cistrome predicted from (b). d
Veriﬁcation of three predicted C/EBPα targets in (c) by ChIP-sequencing readouts available in the public domain (ngs-qc.org). Note that these
three cases were predicted by the various publicly available GRN sources, as indicated by the arrow color-code (displayed in (e)). e The action
of TFs (nodes are color-coded according to gene induction, as indicated at the top) in a GRN generated with TETRAMER, highlighting their
temporal regulation during B-lymphoma to macrophage trans-differentiation. The origin of the integrated edges is color-coded to reveal the
corresponding connectivity data sources
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mediated programs triggered by IRF1, also regarded as tumor
suppressor, as is the late induced TP53. The last observed
programming phase involves TFs like CEBPG,18 known to suppress
oncogene-induced senescence and inﬂammatory gene expres-
sion, MXD1, a regulatory component in the MYC-MAX-MAD
network and heat shock factors (DNAJC2, HSF2). Thus, the
secretome of senescent cells activates a plethora of gene
regulators that apparently substitute for the oncogene-mediated
activities in the stepwise model of human primary cell
transformation.
As ﬁnal example, we used TETRAMER to reconstitute TF wiring
implicated in the trans-differentiation of B-lymphoma cells to
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primary macrophages by over-expressing CEBPA19 (Fig. 2a). In fact,
GRN reconstruction revealed the downstream TF regulatory
cascade initiated by C/EBPα, thus providing a comprehensive
view of the master regulators implicated in this process. This TF
regulatory wiring was reconstituted by integrating TF–TGs
relationships from three GRN databases (CellNet1, CAGE3,
qcChIP-seq6; Fig. 2b). Note both the redundancy (CellNet vs.
qcChIP-seq, TFs depicted at top right; CellNet vs. CAGE, TFs
speciﬁed on left) and the unique retrieval of some TFs (e.g., HIF1A,
MAFF) from different databases, illustrating the advantage of
incorporating multiple sources of TF–TG relationships. Indeed,
albeit in the predicted C/EBPα cistrome (Fig. 2c), FOSL1 was only
retrieved from CAGE, SPI1 only from CellNet, and JUNB only from
the qcChIP-seq database, independent ChIP-seq assays demon-
strated C/EBPα binding proximal to each gene, but beyond the
proximity criterion of the qcChIP-seq collection (enhancer regions
< 10 kb distance to TSS), thus explaining why FOSL1 and SPI1 are
not predicted as C/EBPα targets by this collection (Fig. 2d). The
ﬁnal temporally organized TF network (Fig. 2e) comprises 70 TFs
and 222 relationships, revealing also activation of the endogenous
CEBPA, which may support maintenance of the trans-differentiated
cell state, as it is the case for pluripotency factors in MEF-iPSC
reprogramming (Supplementary Fig. 3).
Given that, in principle, TETRAMER predicts master regulators
for any cell fate transition by evaluating their impact on
transcription regulation throughout the reconstructed network,
we applied this approach to predict master regulators to each
hypothetically possible cell fate transition within a collection of
more than 3000 transcriptomes from ~300 cell/tissue types
representing 14 different anatomical systems in the human body.2
We generated GRNs that corresponded to the transitions
predicted to interconvert any cell/tissue type into any other, and
predicted the TF networks expected to drive these cell fate
transitions (Supplementary Note and Supplementary Fig. 7a).
Finally, the degree of similarity among all inferred TF networks per
cell/tissue types was evaluated (Tanimoto Index; Supplementary
Note) and clustered to reveal the common anatomical origin of
the compared cell/tissue systems (Fig. 3a). As a validation step we
focused on the transition towards M2 macrophages from a variety
of different cell types (~300 cell/tissue types as source; Fig. 3b) and
ranked the transition-implicated TFs according to their capacity to
act as master regulators (“MRI;” Fig. 3c; Supplementary Fig. 5a). In
this manner, we aimed at identifying a consensus TFs for driving
cell fate transition towards macrophage, in despite of the cell
type/tissue in use as source, as well as to overwhelm potential
technical aspects implicated on their prediction. TETRAMER
identiﬁed major players in the transitions from naïve B cells or
primary skin ﬁbroblasts to M2 macrophages (Supplementary Fig.
5b), presenting overlapping but non-identical sets of 11 to 19
master regulators—six of which are common to all three
transitions—depending on whether the transition to M2 macro-
phages was initiated from B cells, ﬁbroblasts, or ES cells (Fig. 3d).
Comparing the predictions of TETRAMER with previous efforts to
deﬁne master regulators (Mogrify,20 CellNet1, D’Alessio et al.2
Supplementary Fig. 6a), revealed a core of TFs commonly
predicted in most approaches (Fig. 3d; Supplementary Fig. 6b),
top ranked on the consensus strategy assessed over ~300 cell/
tissue types (Fig. 3c). Of note, CEBPA was identiﬁed by all but one
approach, clearly suggesting that even the most evident master
regulators can also be missed under deﬁned algorithmic/ cell/
tissue types, thus supporting the consensus strategy.
To assess the versatility of TETRAMER we used it to monitor cell
fate transitions in the context of developing cerebral organoids.21
Speciﬁcally, we used temporal transcriptome data generated from
brain organoid cultures during 60 days.22 TETRAMER predicted
134 TFs with MRI > 25% (p < 10−7) (Fig. 3e). Considering the
complexity of organoids, we expected that the inferred master
regulators would correspond to distinct cell types generated
during this process. Indeed, by comparing the list of top ranked
master regulators with those retrieved on the reconstructed GRNs
associated to the ~300 cell/tissue types discussed above (Fig. 3a
and Supplementary Fig. 7) several predicted TFs were associated
with GRNs operative in a variety of neuronal cell types albeit some
were also associated with non-neuroectodermal cell types (Fig. 3f).
This last aspect was also observed in immunoﬂuorescence assays
with cultured cerebral organoids.23 Taken altogether, this effort
illustrates the potential of TETRAMER to study cell fate transitions
even in complex heterogeneous systems, such as developing
organs.
While in the last years approaches for predicting master
regulators, as molecular targets of pharmacologically relevant
compounds, were developed on the basis of static or dynamic
inferred gene-regulatory maps (DeMAND,24 PROTINA25), their
accessibility by the scientiﬁc community is restricted by the
requirements of using numerical computing environments
(including in some cases the necessity of having a commercial
license). In contrast, TETRAMER is freely available through the
Cytoscape App Store (http://apps.cytoscape.org/apps/tetramer),
and from a dedicated website providing access to the various
networks described in this study (http://igbmc.fr/Gronemeyer/
qcgenomics/TETRAMER). Through this platform, users have the
possibility to query predicted MRs for (i) a given cell transforma-
tion; (ii) the transformation of a given cell towards any other cell
type; and (iii) the transformation of a given cell into any other cell.
Moreover, users can compare the outputs generated by the
Cystoscape app with the collection of GRNs reconstructed for
~300 human cell/tissue types.
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